Governments are playing a bigger role in cell and gene therapy manufacturing
Currently, the UK accounts for 16% of global cell therapy manufacturing facilities, according to GlobalData’s Contract Service Provider Database.
ByHome Trending
ViiV Healthcare unveils Phase III trial results of monthly shots to combat HIV
The results investigated the efficacy and safety of cabotegravir/rilpivirine, the company’s once-monthly injection for treating HIV.
By
GDPR: The Implications for Clinical Development
Eight months in, Nigel Hughes, Scientific Director JCI-PDR, Janssen, examines the ramifications of GDPR on the industry now the regulation…
Medical Device Development – Challenges of an SME
John Shillingford, Clinical Operations Director, Orsus Medical, describes the inherent challenges facing small- to mid-sized medical device companies
MDMA Treatments Found to Eliminate PTSD Symptoms in Phase II Trial
Gavin Davidson, CVMD Analyst, GlobalData, examines how MDMA is used to treat patients with PTSD
How Whole Systems Thinking Could Transform the Clinical Supply Chain
Hedley Rees, Chief Disruptor, PharmaFlow, discusses the need for a rethink on supply chain processes
Managing Blinding Requirements in IRT: An Overview
Francesco Spoto, Clinical Project Manager, explores the opportunities of using IRT solutions to manage blinded information in clinical trials
Integrating New Assets: A Supply Chain Perspective
Barrett Glasser, Associate Director, Clinical Drug Supply, Biogen, provides an overview on how to on board newly acquired therapeutic assets